Search

The biogenic engineered silver nanoparticles (AgNPs) were synthesized using aqueous extract of marine mangrove Avicennia marina leaves and its anticancer activity was checked in lung cancer cell line. Initially, the UV–vis spectra exhibited the characteristics SPR absorption peak for AgNPs at 425 nm and further characterized using TEM, SAED, XRD and FT-IR analysis. The TEM pictures displayed the spherical crystalline and monodispersed nature of AgNPs and the size range observed between 25–30 nm. The SAED showed the AgNPs are face-centered cubic pattern which is further confirmed with XRD analysis. The FTIR spectral analysis exposed the presence of necessary biomolecules for the reduction and stabilization of silver ions. Synthesized AgNPs showed dose-dependent cytotoxic activity in A549 cell line. The fluorescence studies showed that AgNPs induces apoptosis by increasing the generation of ROS in mitochondria and cleaving the mitochondrial membrane of A549 cells. Further, the molecular studies were conducted using RT-PCR and western blotting analysis and the results confirmed that the AgNPs induce apoptosis through both p53-dependent and -independent caspase intermediated signaling pathway. Together, the present study concludes that the bioengineered AgNPs can act as a potential therapeutic agent against lung cancer.

The present study aims to investigate the effect and the molecular mechanism of N-(2-hydroxyphenyl)-2-phenazinamine (NHP) isolated from Nocardiopsis exhalans against the proliferation of human lung cancer cells. The cytotoxic activity of NHP against A549 and H520 cells was determined using MTT assay. The cytotoxic activity of NHP against A549 and H520 lung cancer cells showed excellent activity at 75 μg/mL and damage the mitochondrial membrane and nucleus by generating oxidative stress. NHP causes nuclear condensation and induces apoptosis which was confirmed using AO/EB and PI/DAPI dual staining assay. Moreover, the NHP downregulates the oncogenic genes such as IL-8, TNFα, MMPs and BcL2 and also upregulates the expression of apoptosis marker genes such as Cyto C, p53, p21, caspase 9/3 in A549 and H520 human lung cancer cells. Considering the strong anticancer activity of NHP against lung cancer, NHP may be further evaluated as a potential anticancer drug for the treatment of lung cancer.

The potent biosurfactant-producing marine actinomycete Micromonospora marina was isolated from the mucus of the scleractinia coral Acropora formosa. The strain was screened for biosurfactant production and showed positive signs for hemolytic activity, drop-collapse test, oil displacement, emulsification activity and lipase production. The yield of biosurfactant was found to be high when the medium containing sucrose and peptone were used as carbon and nitrogen sources, respectively. The chemical characterization of the biosurfactant confirmed the presence of proteins, lipids and carbohydrates, thus indicating that the biosurfactant was lipopeptide in nature. Further, the presence of palmitoleic acid in GC–MS analysis also confirmed that the produced biosurfactant was a surfactin derivative. The structural characterization of surfactin was confirmed by 1H NMR and 13C NMR, and the results showed the presence of mystric fatty acid (−CH3CH2-), palmitoleic acid, lipopeptide monoesters and aromatic protons and carbons. Further, the surfactin exhibited potential cytotoxic activity against human breast cancer cells by inducing apoptosis through the increase of ROS generation and cleaving mitochondrial membrane potential. Taken together, the surfactin produced by M. marina could act as an excellent anticancer agent against breast cancer.

The aim of the current study is to identify bioactive compound from marine endophytic actinomycetes (MEA) isolated from Gulf of Mannar region, Southeast coast of India. Among the isolated actinomycetes, strain GRG 4 exhibited excellent ability to inhibit isolated colistin resistant (CR) Pseudomonas aeruginosa (P. aeruginosa) and Klebsiella pneumoniae (K. pneumoniae), which is a emerging threat to the world. The strain was identified as Streptomyces coeruleorubidus GRG 4 (KY457708), based on morphological, biochemical, phenotypic and genotypic characters. The bioactive metabolites present in the methanolic extract were partially purified by TLC and preparative HPLC. The active HPLC fraction 2 showed 15, 20 mm zone of inhibition against both CR P. aeruginosa and K. pneumoniae respectively. Analytical HPLC and FT-IR results of fraction 2 showed with carbonyl group. Both GC-MS and LC-MS results confirmed that the fraction 2 contained chemical constituents of Bis (2-Ethylhexyl) Phthalate (BEP). The compromised structure with loosely integrated and ruptured cell wall of BEP treated CR bacteria were observed by confocal laser scanning microscope (CLSM) and scanning electron microscope (SEM) at 75 μg/mL of minimum inhibitory concentration (MIC) dose. Further, cytotoxic effect of BEP against A549 human lung cancer cells revealed complete inhibition by cell proliferation and apoptosis was observed at 100 μg/mL in 24 h treatment. In addition, irreversible ROS dependent oxidative damage was clearly observed at the IC50 concentration of BEP. The toxicity of BEP was also studied against Vibrio fischeri (V. fischeri) and found to be highly toxic after 15 and 30 min of treatment. Based on the results it could be concluded that the identified compound BEP is a potent inhibitor for CR bacteria and A549 lung cancer cells.

Lung cancer is the leading cause of cancer-related death globally. Despite many advanced approaches to treat cancer, they are often ineffective due to resistance to classical anti-cancer drugs and distant metastases. Currently, alternative medicinal agents derived from plants are the major interest due to high bioavailability and fewer adverse effects. Tannins are polyphenolic compounds existing as specialized products in a wide variety of vegetables, fruits, and nuts. Many tannins have been found to possess protective properties, such as anti-inflammatory, anti-fibrotic, anti-microbial, anti-diabetic, and so on. This review aims to summarize the current knowledge addressing the anti-cancer effects of dietary tannins and their underlying molecular mechanisms. In vivo and in vitro studies provide evidences that anti-cancer effects of various tannins are predominantly mediated through negative regulation of transcription factors, growth factors, receptor kinases, and many oncogenic molecules. In addition, we also discussed the absorption, distribution, metabolism, excretion, and toxicity (ADMET) properties of tannins, clinical trial results as well as our perspective on future research with tannins.

Over a few decades, systemic chemotherapy and surgery are the only treatment options for lung cancer. Due to limited efficacy and overall poor survival of patients, it is necessary to develop a newer therapeutic strategy which specifically targets cancer cell proliferation pathway. Deciphering the role of long non-coding RNAs (lncRNAs) in tumorigenesis and pathogenesis of cancer cells has recently emerged. In the present study, marine actinomycetes derived 1-hydroxy-1-norresistomycin (HNM) was used to enhance the expression of lncRNAs through p53 transcriptional regulation and induced intrinsic apoptosis in non-small cell lung cancer cells. Initially, concentration dependent treatment with HNM has increased the ROS generation in mitochondria and sensitizes the mitochondrial membrane potential. Further, HNM downregulates the numerous oncogenes which regulate cancer cell proliferation, metastasis and invasion and tumor suppressor genes which are involved in intrinsic apoptosis confirmed with adopting techniques such as RT-PCR and western blot analysis. Moreover, ChIP assay results showed that HNM upregulates the p53 mediated transcriptional regulation of lncRNAs lead to apoptosis of cancer cells through cell cycle arrest and inhibition of proliferation. In conclusion, HNM found to be a potential therapeutic agent for treatment of lung cancer via suppression of oncogenes and expression of wide range of tumor suppressor genes are might have significant implications in cancer treatment and drug development.

Copper oxide nanoparticles (CuO NPs) promoting anticancer activity may be due to the regulation of various classes of histone deacetylases (HDACs). Green-synthesized CuO NPs significantly arrested total HDAC level and also suppressed class I, II and IV HDACs mRNA expression in A549 cells. A549 cells treated with CuO NPs downregulated oncogenes and upregulated tumor suppressor protein expression. CuO NPs positively regulated both mitochondrial and death receptor-mediated apoptosis caspase cascade pathway in A549 cells. Green-synthesized CuO NPs inhibited HDAC and therefore shown apoptosis mediated anticancer activity in A549 lung cancer cell line.

Nanomaterials based fluorescent agents are rapidly becoming significant and promising transformative tools for improving medical diagnostics for extensive in vivo imaging modalities. Compared with conventional fluorescent agents, nano-fluorescence has capabilities to improve the in vivo detection and enriched targeting efficiencies. In our laboratory we synthesized fluorescent metal nanoparticles of silver, copper and iron using Curcuma longa tuber powder by simple reduction. The physicochemical properties of the synthesized metal nanoparticles were attained using UV–visible spectrophotometry, scanning electron microscopy with EDAX spectroscopy, dynamic light scattering, Fourier-transform infrared spectroscopy and X-ray diffraction. The Curcuma longa tuber powder has one of the bioactive compound Curcumin might act as a capping agent during the synthesis of nanoparticles. The synthesized metal nanoparticles fluorescence property was confirmed by spectrofluorometry. When compared with copper and iron nanoparticles the silver nanoparticles showed high fluorescence intensity under spectrofluorometry. Moreover, in vitro cell images of the silver nanoparticles in A549 cell lines also correlated with the results of spectrofluorometry. These silver nanoparticles show inspiring cell-imaging applications. They enter into cells without any further modifications, and the fluorescence property can be utilized for fluorescence-based cell imaging applications.

Lack of markers of subclinical disease state and clinical phenotype other than pulmonary function test has made the diagnosis and interventions of environmental respiratory diseases a major challenge. MicroRNAs (miRNAs), small non-coding single stranded RNAs, have emerged as potential disease-modifier in various environmental respiratory diseases. They can also be found in various body fluids and are remarkably stable. Because of their high stability, disease-specific expression, and the ease to detect and quantify them have raised the potential of miRNAs in body fluids to be useful clinical diagnostic biomarkers for lung disease phenotyping. In the present review, we provide a comprehensive overview of progress made in identifying miRNAs in various body fluids including blood, serum, plasma, bronchoalveolar lavage (BAL) fluid, and sputum as biomarkers for a wide range of human respiratory diseases such as acute lung injury/acute respiratory distress syndrome (ALI/ARDS), idiopathic pulmonary fibrosis (IPF), chronic obstructive pulmonary disease (COPD), and asthma. Finally, we discuss several challenges remain to be concerned and suggest few disease-specific and non-specific miRNAs to become part of future clinical practice.

Neuroblastoma is the most common tumor amongst children amounting to nearly 15% of cancer deaths. This cancer is peculiar in its characteristics, exhibiting differentiation, maturation and metastatic transformation leading to poor prognosis and low survival rates among children. Chemotherapy, though toxic to normal cells, has shown to improve the survival of the patient with emphasis given more towards targeting angiogenesis. Recently, Tideglusib was designed as an 'Orphan Drug' to target the neurodegenerative Alzheimer's disease and gained significant momentum in its function during clinical trials. Duffy et al. recently reported a reduction in cell viability of human IMR32 neuroblastoma cells when treated with Tideglusib at varying concentrations. We investigated the effects of Tideglusib, at various concentrations, compared to Lithium chloride at various concentrations, on IMR32 cells. Lithium, a known GSK-3 inhibitor, was used as a standard to compare the efficiency of Tideglusib in a dose-dependent manner. Cell viability was assessed by MTT assay. The stages of apoptosis were evaluated by AO/EB staining and nuclear damage was determined by Hoechst 33258 staining. Reactive oxygen species (ROS) and mitochondrial membrane potential (ΔΨm) were assessed by DCFDA dye and Rhodamine-123 dye, respectively. Tideglusib reported a significant dose-dependent increase in pro-apoptotic proteins (PARP, Caspase-9, Caspase-7, Caspase-3) and tumor-related genes (FasL, TNF-α, Cox-2, IL-8, Caspase-3). Anti-GSK3 β, pGSK3 β, Bcl-2, Akt-1, p-Akt1 protein levels were observed with cells exposed to Tideglusib and Lithium chloride. No significant dose-dependent changes were observed for the mRNA expression of collagenase MMP-2, the tumor suppressor p53, or the cell cycle protein p21. Our study also reports Tideglusib reducing colony formation and increasing the level of sub-G0/G1 population in IMR32 cells. Our investigations report the significance of Tideglusib as a promising apoptotic inducer in human neuroblastoma IMR32 cells. Our study also reports that LiCl reduced cell viability in IMR32 cells inducing apoptosis mediated by ROS generation.

Over the past few centuries, interest in novel metal nanoparticles has expanded quickly with the inclusion of new nanocomposites into a variety of products and technologies. Recently, nanocomposites prepared by the distribution of inorganic nanoparticles in polymeric matrices have found a prominent role in biomedical applications. In this report, we attempt to formulate a biodegradable poly-D,L-lactide-co-glycolide (PLGA) polymer based biogenic silver nanocomposite using a modified solvent casting method. The silver nanoparticles mediated by Origanum vulgare aqueous leaf extract (Ag NPs) and formulated silver polymeric nanocomposite (PLGA/Ag NC) show absorbance spectra at 420 nm under UV-visible spectroscopy. Fourier transform infrared spectroscopy confirms that Ag NPs utilized the carbonyl functional group present in the PLGA polymer for the successful formation of PLGA/Ag NC. Scanning electron microscopy analysis notably showed that PLGA/Ag NC was found to be spherical and irregular in shape, distributed in the polymer matrix. A dynamic light scattering measurement showed that PLGA/Ag NC has an average particle size distribution of 115 nm, and the zeta potential was −33 mV. The PLGA/Ag NC crystalline nature was confirmed using X-ray diffraction analysis. Furthermore, PLGA/Ag NC improves wound healing in the excision wound which was established using wound closure, histopathology, protein profiling, and matrix metalloproteinases 2 and 9 expression. The analysis results clearly show that PLGA/Ag NC enhances the wound healing activity by the sustained release of Ag NPs, upregulates protein expression and inhibits pathogenic bacterial growth in the wound area. In conclusion, PLGA/Ag NC could be a novel therapeutic agent for wound treatment.

A novel glycolipid biosurfactant produced from Staphylococcus aureus was used to induce apoptosis in HeLa cells. The production of the biosurfactant was optimized using different carbon and nitrogen sources. Sucrose and sodium nitrate were found to be the best substrates among the tested carbon and nitrogen sources, which showed a high growth, yield and emulsification activity. The produced biosurfactant was characterized using GC-MS analysis and the results showed the presence of palmitoleic acid, oleic acid, 1,2-benzenedicarboxylic acid and linoleic acid, confirming that the biosurfactant was glycerol derived in nature. FTIR results confirmed the presence of sugar residues and an α-pyranose form of glucose residues, and 1H NMR analysis showed the presence of a glycerol moiety with signals at 3.5 ppm for the –CH2 groups and 3.8 ppm for the –CH groups. We found that this glycolipid induced a significant reduction in the HeLa cell viability in a dose dependent manner. This was further confirmed through AO/EB and DCFH-DA staining, which revealed that the glycolipids were actively involved in the induction of apoptosis in HeLa cells. Moreover, after 24 h of exposure the glycolipids induce S phase and G2/M cell cycle arrest in HeLa cells.

Polymeric nanocomposites have gained extensive attention in modern nanotechnology by reason of its design, flexibility, sole applications and lower life cycle costs. Preparation of composites using spreading of inorganic metal nanoparticles in organic polymeric matrices has plenty of scope and applications in the biomedical field. Poly-D,l-lactide-co-glycolide (PLGA) is an appreciated polymer for composites preparation because of its non-toxic and promising biodistribution. The consideration of metal nanoparticles has extended rapidly with the presence of new nanocomposites into a range of products and technologies. Compared to bulk materials the synthesized metal nanoparticles have unique character and biomedical uses due to its shape, size, and huge surface to volume ratio. Among different inorganic metal nanoparticles, silver nanoparticles (Ag NPs) have dominated in the biomedical field owing to its diverse potential applications including imaging, sensor, diagnosis and disease treatment. Further, medicinal plant extract mediated Ag NPs shown superior advantages and its antimicrobial based wound healing prospective has been established. However, not much information on plant extract mediated Ag NPs integrated PLGA nanocomposites wound healing applications. In the present review, we discussed necessity, preparation, characterization and antimicrobial based wound healing mechanism of incorporated plant extract mediated silver/PLGA nanocomposites.

This study aims to unravel the use of GSK-3 inhibitors as viable apoptotic inducers for teratocarcinoma-derived ovarian PA-1 cells. MTT assay was carried out to assess inhibitory concentrations of LiCl and TDG. AO/EB staining and Hoechst 33258 staining were employed to assess the damage. Mitochondrial membrane potential (ΔΨm) and ROS generation were assessed with IC50 concentrations of LiCl and TDG. Tumor-related genes (p53, p21, IL-8, TNF-α, MMP-2, Fas-L, Cox-2, and caspase-3) were assessed with 1/4 IC50, 1/2 IC50, IC50 concentrations by semi-quantitative RT- PCR. Cell cycle analysis was performed with IC50 concentration of LiCl and TDG. Western blot analysis was performed for caspase-3, caspase-7, caspase-9, PARP to estimate the possible damage induced by GSK-3 inhibitors and regulation of GSK-3β, pGSK-3β, Cox-2. GSK-3 inhibitors demonstrated a concentration and time-dependent reduction in cell viability, exhibiting significant ROS generation and reduced ΔΨm at their IC50 values. Substantial concentration-dependent gene expression changes with significant upregulation of P21, Cox-2, TNF-α, caspase-3, Fas-L were observed. Protein expression of caspase-3 caspase-7, caspase-9, PARP exhibited significant cleavage in LiCl and TDG-treated cells. Protein expression of Cox-2 was significantly increased in IC50 concentration of TDG. Cell cycle analysis showed significant accumulation of cells at sub-G0-G1.

With the objective to provide a potential approach for the treatment of lung cancer, nanotechnology based Suberoylanilide hydroxamic acid (SAHA)-loaded Poly-d, l-lactide-co glycolide (PLGA) nanoparticles have been formulated using the nanoprecipitation technique. The acquired nanoparticles were characterized by various throughput techniques and the analyses showed the presence of smooth and spherical shaped SAHA-loaded PLGA nanoparticles, with an encapsulation efficiency of 44.8% and a particle size of 208nm. The compatibility between polymer and drug in the formulation was tested using FT-IR, Micro-Raman spectrum and DSC thermogram analyses, revealing a major interaction between the drug and polymer. The in vitro drug release from the SAHA-loaded PLGA nanoparticles was found to be biphasic with an initial burst followed by a sustained release for up to 50h. In experiments using the lung cancer cell line A549, SAHA-loaded PLGA nanoparticles demonstrated a superior antineoplastic activity over free SAHA. In conclusion, SAHA-loaded PLGA nanoparticles may be a useful novel approach for the treatment of lung cancer.

Developing surfactant based metal complexes as metallodrugs is a promising approach for which it is important to know the effect of their hydrophobic tail part on the interaction with biomacromolecules as well as on their biological activities. In this report we describe some surfactant–cobalt(III) complexes differing in their tail part and the effect of hydrophobicity of these complexes on their interaction with calf thymus DNA and on the cytotoxic activities. The obtained results along with molecular docking calculations show that the single chain surfactant–cobalt(III) complexes interact with DNA via groove binding and double chain surfactant–cobalt(III) complexes interact with DNA through partial intercalation. In tune with this, double chain systems show more anticancer activity as their hydrophobic tail part makes them effectively penetrate into the cell. So, this kind of tuning of the hydrophobicity of metallodrugs will lead to optimisation of the DNA binding and cytotoxicity behaviour.

In the present study, a chemical route was employed to synthesize graphene oxide (GO)-reduced graphene oxide (rGO)-Ag nanoparticle (AgNP) composites from graphite and AgNO3 using vitamin C as reducing agent. Powder X-ray diffraction pattern and field emission scanning electron microscope images revealed that the AgNP were uniformly distributed on the surface of GO and rGO nanosheets. For the first time, the cytotoxicity of GO, rGO, AgNP, GO-AgNP and rGO-AgNP composites were examined against human lung cancer A549 cells using MTT assay and reported quantitatively. The rGO-AgNP showed significant cytotoxicity activity with an IC50 value of 30μg/mL towards A549 cells which is higher than that of GO (180μg/mL), rGO (160μg/mL) and GO-AgNP (100μg/mL). Compared to AgNP (6μg/mL), rGO-AgNP shows partial agglomeration of AgNP on rGO sheets, which reduces the interaction between rGO-AgNP and A549 cells leading to lesser anticancer activity than AgNP. The interaction between rGO and AgNP leads to increase in the material biocompatibility, reducing the toxicity and corrosive characteristic.

Titanium dioxide nanoparticles were effectively synthesized from aqueous leaf extract of Azadirachta indica under pH and temperature-dependent condition. 5 mM titanium isopropoxide solution worked as a primary source for the synthesis of titanium dioxide nanoparticles. The green synthesized titanium dioxide nanoparticles were confirmed by UV–Vis spectroscopy. Fourier transform infrared spectrum of synthesized titanium dioxide nanoparticles authorized the presence of bioactive compounds in the leaf extract, which may play a role as capping and reducing agent. The high-resolution scanning electron microscopy and dynamic light scattering analyses results showed the interconnected spherical in shape titanium dioxide nanoparticles having a mean particle size of 124 nm and a zeta potential of −24 mV. Besides, the colloidal titanium dioxide nanoparticles energetically degrade the industrially harmful methyl red dye under bright sunlight.

The design, synthesis, characterization and application of biologically synthesized nanomaterials have become a vital branch of nanotechnology. There is a budding need to develop a method for environmentally benign metal nanoparticle synthesis, that do not use toxic chemicals in the synthesis protocols to avoid adverse effects in medical applications. Here, it is a report on an eco-friendly process for rapid synthesis of copper oxide nanoparticles using Ficus religiosa leaf extract as reducing and protecting agent. The synthesized copper oxide nanoparticles were confirmed by UV-vis spectrophotometer, absorbance peaks at 285 nm. The copper oxide nanoparticles were analyzed with field emission-scanning electron microscope (FE-SEM), Fourier transform infrared (FT-IR) spectroscopy, dynamic light scattering (DLS) and X-ray diffraction (XRD) spectrum. The FE-SEM and DLS analyses exposed that copper oxide nanoparticles are spherical in shape with an average particle size of 577 nm. FT-IR spectral analysis elucidates the occurrence of biomolecules required for the reduction of copper oxide ions. Zeta potential studies showed that the surface charge of the formed nanoparticles was highly negative. The XRD pattern revealed that synthesized nanoparticles are crystalline in nature. Further, biological activities of the synthesized nanoparticles were confirmed based on its stable anti-cancer effects. The apoptotic effect of copper oxide nanoparticles is mediated by the generation of reactive oxygen species (ROS) involving the disruption of mitochondrial membrane potential (Δψm) in A549 cells. The observed characteristics and results obtained in our in vitro assays suggest that the copper nanoparticles might be a potential anticancer agent.

The biodegradable polymeric nanoparticles have been potentially used to carry various chemotherapy agents into cancer cells for targeted drug delivery. Conversely, the biodistribution and toxic effects of these drug-loaded nanoparticles have raised some concerns. In the present study, we tried to explore the prospective histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) loaded poly (DL-lactide-co-glycolide) (PLGA) nanoparticles biocompatibility and biodistribution in animal system. The biocompatibility of SAHA loaded PLGA nanoparticles were evaluated through hemolysis, biochemical and histopathological analysis. The analysis results showed SAHA loaded PLGA nanoparticles has good hemocompatibility, not at all an elevation of blood biochemical parameters and no specific remarkable tissues changes in liver, kidney, lung, and heart as compared with control. The orally administered SAHA loaded PLGA nanoparticles distributions in various organs were confirmed using spectrofluorometry and fluorescence microscope. The results shows nanoparticles were remained detectable in the liver, kidney, heart and lung tissues after 3 days. Moreover, the SAHA loaded PLGA nanoparticles are actively taken up in the A549 lung cancer cells. The overall results conclude that the histone deacetylase inhibitor SAHA loaded PLGA nanoparticles is biocompatible and actively distributed various organs in the animal system. The biocompatible SAHA loaded PLGA nanoparticles may be a suitable anticancer agent in the near feature.

The cyanobacterium Microcystis aeruginosa can potentially proliferate in a wide range of freshwater bionetworks and create extensive secondary metabolites which are harmful to human and animal health. The M. aeruginosa release toxic microcystins that can create a wide range of health-related issues to aquatic animals and humans. It is essential to eliminate them from the ecosystem with convenient method. It has been reported that engineered metal nanoparticles are potentially toxic to pathogenic organisms. In the present study, we examined the growth inhibition effect of green synthesized copper oxide nanoparticles against M. aeruginosa. The green synthesized copper oxide nanoparticles exhibit an excitation of surface plasmon resonance (SPR) at 270 nm confirmed using UV-visible spectrophotometer. The dynamic light scattering (DLS) analysis revealed that synthesized nanoparticles are colloidal in nature and having a particle size of 551 nm with high stability at -26.6 mV. The scanning electron microscopy (SEM) analysis shows that copper oxide nanoparticles are spherical, rod and irregular in shape, and consistently distributed throughout the solution. The elemental copper and oxide peak were confirmed using energy dispersive x-ray analysis (EDAX). Fourier-transform infrared (FT-IR) spectroscopy indicates the presence of functional groups which is mandatory for the reduction of copper ions. Besides, green synthesized copper oxide nanoparticles shows growth inhibition against M. aeruginosa. The inhibition efficiency was 31.8 % at lower concentration and 89.7 % at higher concentration of copper oxide nanoparticles, respectively. The chlorophyll (a and b) and carotenoid content of M. aeruginosa declined in dose-dependent manner with respect to induction of copper oxide nanoparticles. Furthermore, we analyzed the mechanism behind the cytotoxicity of M. aeruginosa induced by copper oxide nanoparticles through evaluating membrane integrity, reactive oxygen species (ROS), and mitochondrial membrane potential (Δψm) level. The results expose that there is a loss in membrane integrity with ROS formation that leads to alteration in the Δψm, which ends up with severe mitochondrial injury in copper oxide nanoparticles treated cells. Hence, green way synthesized copper oxide nanoparticles may be a useful selective biological agent for the control of M. aeruginosa.